Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03873805
Recruitment Status : Recruiting
First Posted : March 13, 2019
Last Update Posted : December 26, 2019
National Cancer Institute (NCI)
Information provided by (Responsible Party):
City of Hope Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 21, 2021
Estimated Study Completion Date : February 21, 2021